Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TNYA Tenaya Therapeutics > Detailed Quotes

TNYA Tenaya Therapeutics

3.150
+0.140+4.65%
Close 10/04 16:00 ET
High
3.230
Open
3.080
Turnover
372.65K
Low
3.050
Pre Close
3.010
Volume
118.63K
Market Cap
130.30M
P/E(TTM)
Loss
52wk High
32.000
Shares
41.36M
P/E(Static)
Loss
52wk Low
2.770
Float Cap
60.04M
Bid/Ask %
-83.67%
Historical High
32.000
Shs Float
19.06M
Volume Ratio
0.68
Historical Low
2.770
Dividend TTM
--
Div Yield TTM
--
P/B
0.58
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.62%
Amplitude
5.98%
Avg Price
3.141
Lot Size
1
Float Cap
60.04M
Bid/Ask %
-83.67%
Historical High
32.000
Shs Float
19.06M
Volume Ratio
0.68
Historical Low
2.770
Dividend TTM
--
P/B
0.58
Dividend LFY
--
Turnover Ratio
0.62%
Amplitude
5.98%
Avg Price
3.141
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in August 2016 and is headquartered in South San Francisco, CA.
CEO: Mr. Faraz Ali, M.B.A.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...